AKORN FDA Approval ANDA 207217

ANDA 207217

AKORN

FDA Drug Application

Application #207217

Application Sponsors

ANDA 207217AKORN

Marketing Status

Prescription001

Application Products

001OINTMENT;TOPICAL100,000 UNITS/GM;0.1%0NYSTATIN AND TRIAMCINOLONE ACETONIDENYSTATIN; TRIAMCINOLONE ACETONIDE

FDA Submissions

UNKNOWN; ORIG1AP2017-08-04STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAT

CDER Filings

AKORN
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 207217
            [companyName] => AKORN
            [docInserts] => ["",""]
            [products] => [{"drugName":"NYSTATIN AND TRIAMCINOLONE ACETONIDE","activeIngredients":"NYSTATIN; TRIAMCINOLONE ACETONIDE","strength":"100,000 UNITS\/GM;0.1%","dosageForm":"OINTMENT;TOPICAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"08\/04\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2017-08-04
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.